Clever Culture Systems (ASX:CC5) Moat Score: 0/10 (As of Jun. 29, 2026)


What is Clever Culture Systems Moat Score?

Clever Culture Systems has the Moat Score of 0, which implies that the company might have No Moat - No discernible moat.

Clever Culture Systems has

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Clever Culture Systems might have No Moat - No discernible moat.

Clever Culture Systems  (ASX:CC5) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Clever Culture Systems Moat Score Related Terms

Clever Culture Systems Business Description

Address 16 Anster Street, Adelaide, SA, AUS, 5000
Clever Culture Systems Ltd provides intelligent automation solutions to microbiology laboratories. The Company has developed a technology, the Automated Plate Assessment System (APAS Independence), using artificial intelligence and machine learning software to automate the imaging, analysis, and interpretation of microbiology culture plates. The technology remains the only U.S. FDA-cleared artificial intelligence technology for automated culture plate reading. The Group operates in one business segment, researching, developing, and commercialising innovative technologies. Its geographic areas are Australia, the UK, Sweden, the Netherlands, and Others. It generates the majority revenue from the Australia region.